Synthetic Design Lab

Precision by Design

South San Francisco, United States · Founded 2024 · $20.0M raised

Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$20.0M
Last Round
$20.0M SeedApr 2025
Rounds
1

About

Synthetic Design Lab is a next-generation antibody-drug conjugate (ADC) biotech company based in the San Francisco Bay Area, building cancer therapeutics on novel synthetic biology foundations. The company's proprietary SYNTHBODY platform enables synthetic targeting with multilayered logic control, achieving over 10x improvement in targeted cancer cell killing compared to conventional IgG-based ADCs. Founded by oncology veterans from Genentech and IGM Biosciences — including Dr. Daniel S. Chen, who led clinical development of atezolizumab (TECENTRIQ) — the company launched with a $20 million seed round in April 2025 and is advancing a pipeline of precision therapeutics for difficult-to-treat cancers.

Summary

Synthetic Design Lab is a Biotech company based in South San Francisco, United States, founded in 2024. It has raised $20.0M in total across 1 round, most recently a $20.0M Seed round in Apr 2025. Investors include Playground Global, Godfrey Capital and Goldcrest Capital.

Sign up to view the funding chart

Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundApr 2025
$20.0M

Investors

Similar Companies